Patents by Inventor Tim WESSER

Tim WESSER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Analogs of CYP-Eicosanoids for Use in Treating or Preventing a Disorder Associated with Neovascularization and/or Inflammation
    Publication number: 20210353569
    Abstract: The present invention relates to compounds according to general formula (I) which are metabolically robust analogues of bioactive lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFAs) for use in treating or reducing the risk of developing or preventing: (i) neovascularization and/or (ii) inflammatory disorder, in particular, ophthalmic disorders associated with neovascularization and/or inflammation.
    Type: Application
    Filed: July 22, 2021
    Publication date: November 18, 2021
    Inventors: Robert Fischer, Wolf-Hagen Schunck, Dominik Müller, Tim Wesser, Anne Konkel, Janine Lossie
  • Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease
    Patent number: 11096910
    Abstract: The present invention relates to compounds according to general formula (I) which are metabolically robust analogues of bioactive lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFAs). The present invention further relates to compositions containing one or more of these compounds and to the use of these compounds or compositions for the treatment or prevention of cardiovascular diseases.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: August 24, 2021
    Assignees: Max Delbruck-Centrum Fur Molekulare Medizin, The Board of Regents of the University of Texas System, Omeicos Therapeutics GmbH
    Inventors: Robert Fischer, Anne Konkel, Tim Wesser, Philipp Westphal, Wolf-Hagen Schunk, Christina Westphal, John Russell Falck
  • METABOLICALLY ROBUST ANALOGS OF CYP-EICOSANOIDS FOR THE TREATMENT OF CARDIAC DISEASE
    Publication number: 20190133976
    Abstract: The present invention relates to compounds according to general formula (I) which are metabolically robust analogues of bioactive lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFAs). The present invention further relates to compositions containing one or more of these compounds and to the use of these compounds or compositions for the treatment or prevention of cardiovascular diseases.
    Type: Application
    Filed: July 22, 2016
    Publication date: May 9, 2019
    Inventors: Robert FISCHER, Anne KONKEL, Tim WESSER, Philipp WESTPHAL, Wolf-Hagen SCHUNK, Christina WESTPHAL, John Russell FALCK
  • ANALOGS OF CYP-EICOSANOIDS FOR USE IN TREATING OR PREVENTING A DISORDER ASSOCIATED WITH NEOVASCULARIZATION AND/OR INFLAMMATION
    Publication number: 20190117597
    Abstract: The present invention relates to compounds according to general formula (I) which are metabolically robust analogues of bioactive lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFAs) for use in treating or reducing the risk of developing or preventing: (i) neovascularization and/or (ii) inflammatory disorder, in particular, ophthalmic disorders associated with neovascularization and/or inflammation.
    Type: Application
    Filed: April 3, 2017
    Publication date: April 25, 2019
    Inventors: Robert FISCHER, Wolf-Hagen SCHUNCK, Dominik MÜLLER, Tim WESSER, Anne KONKEL, Janine LOSSIE